Full Press Release Details
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
This is to inform that the Company has received five separate orders from GST Authority towards tax demand including interest and levying penalty for the period FY 2018-19 to FY 2022-23. The details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are as hereunder:
| S.No. | Name of the authority | : | Joint Commissioner, Office of Principal Commissioner of Central Tax, Visakhapatnam |
| 1 | Nature and details of the action(s) taken, or order(s) passed | : | The Company has received such orders seeking demand including interest and levying penalty under APGST Act 2017. |
| 2 | Date of receipt of direction or order, including any ad-interim or interim orders, or any other communication from the authority | : | Orders dated December 31, 2025, were received by the Company on December 31, 2025. |
| 3 | Details of the violation(s)/ contravention(s) committed or alleged to be committed | : | The authority has passed the orders on the ground that the Company has availed excess input tax credit. |
| 4 | Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible | : | The above orders levy penalty as detailed below: Financial Year Penalty (INR) FY 2018-19 1,89,30,110 FY 2019-20 80,41,186 FY 2020-21 3,52,95,063 FY 2021-22 1,45,04,023 FY 2022-23 70,86,675 Based on our evaluation, there is no material impact on the financials, operations, or other activities of the Company. |
The Company will evaluate filing necessary appeal with the appellate authority in this regard.
This is for your information and records.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer & Head-CSR